[Drug-related motor disorders in aged people].
Martí-Massó
J F
JF
Servicio de Neurología, Hospital Ntra. Sra. de Aránzazu, San Sebastián, Guipúzcoa, España.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects*; D000368:Aged; D000375:Aging; D000978:Antiparkinson Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D011596:Psychomotor Disorders / Q000209:etiology*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D002121:Calcium Channel Blockers; D007980:Levodopa; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine